DK0891326T3 - Nye D-vitaminanaloger - Google Patents
Nye D-vitaminanalogerInfo
- Publication number
- DK0891326T3 DK0891326T3 DK97917272T DK97917272T DK0891326T3 DK 0891326 T3 DK0891326 T3 DK 0891326T3 DK 97917272 T DK97917272 T DK 97917272T DK 97917272 T DK97917272 T DK 97917272T DK 0891326 T3 DK0891326 T3 DK 0891326T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- analogs
- new vitamin
- sec
- compounds
- Prior art date
Links
- 229930003316 Vitamin D Natural products 0.000 title 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title 1
- 235000019166 vitamin D Nutrition 0.000 title 1
- 239000011710 vitamin D Substances 0.000 title 1
- 150000003710 vitamin D derivatives Chemical class 0.000 title 1
- 229940046008 vitamin d Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9607034.7A GB9607034D0 (en) | 1996-04-03 | 1996-04-03 | Chemical compounds |
| PCT/DK1997/000128 WO1997037972A1 (en) | 1996-04-03 | 1997-03-21 | Novel vitamin d analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0891326T3 true DK0891326T3 (da) | 2002-01-28 |
Family
ID=10791549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97917272T DK0891326T3 (da) | 1996-04-03 | 1997-03-21 | Nye D-vitaminanaloger |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5932565A (cs) |
| EP (1) | EP0891326B1 (cs) |
| JP (1) | JP2000508635A (cs) |
| KR (1) | KR100478741B1 (cs) |
| CN (1) | CN1075809C (cs) |
| AT (1) | ATE206394T1 (cs) |
| AU (1) | AU713630B2 (cs) |
| CZ (1) | CZ290097B6 (cs) |
| DE (1) | DE69707121T2 (cs) |
| DK (1) | DK0891326T3 (cs) |
| ES (1) | ES2163144T3 (cs) |
| GB (1) | GB9607034D0 (cs) |
| HU (1) | HUP9901600A3 (cs) |
| NZ (1) | NZ329531A (cs) |
| PL (1) | PL186771B1 (cs) |
| PT (1) | PT891326E (cs) |
| RO (1) | RO118286B1 (cs) |
| RU (1) | RU2169142C2 (cs) |
| WO (1) | WO1997037972A1 (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001030751A2 (en) * | 1999-10-25 | 2001-05-03 | Strakan Limited | USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF |
| US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
| US6358939B1 (en) * | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| WO2001074764A1 (en) * | 2000-03-30 | 2001-10-11 | Teijin Limited | Intermediates for vitamin d and processes for the preparation thereof |
| AUPR731901A0 (en) * | 2001-08-28 | 2001-09-20 | Goodchild, Colin Stanley | Method of treatment |
| CA2586679A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| KR20170096238A (ko) | 2009-01-27 | 2017-08-23 | 베르그 엘엘씨 | 화학요법과 연관된 부작용을 경감시키기 위한 비타민 ｄ３ 및 이의 유사물 |
| EP3603646B1 (en) | 2009-08-14 | 2024-04-03 | BPGbio, Inc. | Vitamin d3 and analogs thereof for treating alopecia |
| SG11201509715UA (en) | 2013-05-29 | 2015-12-30 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69213844T2 (de) * | 1991-07-05 | 1997-04-10 | Duphar Int Res | Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür |
| JP3493037B2 (ja) * | 1991-12-18 | 2004-02-03 | 中外製薬株式会社 | ２２−オキサコレカルシフェロール誘導体とその製造方法 |
-
1996
- 1996-04-03 GB GBGB9607034.7A patent/GB9607034D0/en active Pending
-
1997
- 1997-03-21 RU RU98119976/04A patent/RU2169142C2/ru not_active IP Right Cessation
- 1997-03-21 PT PT97917272T patent/PT891326E/pt unknown
- 1997-03-21 AT AT97917272T patent/ATE206394T1/de not_active IP Right Cessation
- 1997-03-21 CZ CZ19988A patent/CZ290097B6/cs unknown
- 1997-03-21 JP JP9535756A patent/JP2000508635A/ja not_active Ceased
- 1997-03-21 KR KR10-1998-0700504A patent/KR100478741B1/ko not_active Expired - Fee Related
- 1997-03-21 HU HU9901600A patent/HUP9901600A3/hu unknown
- 1997-03-21 DK DK97917272T patent/DK0891326T3/da active
- 1997-03-21 EP EP97917272A patent/EP0891326B1/en not_active Expired - Lifetime
- 1997-03-21 RO RO98-00072A patent/RO118286B1/ro unknown
- 1997-03-21 PL PL97324635A patent/PL186771B1/pl not_active IP Right Cessation
- 1997-03-21 CN CN97190740A patent/CN1075809C/zh not_active Expired - Fee Related
- 1997-03-21 AU AU25670/97A patent/AU713630B2/en not_active Ceased
- 1997-03-21 NZ NZ329531A patent/NZ329531A/en unknown
- 1997-03-21 DE DE69707121T patent/DE69707121T2/de not_active Expired - Fee Related
- 1997-03-21 WO PCT/DK1997/000128 patent/WO1997037972A1/en not_active Ceased
- 1997-03-21 ES ES97917272T patent/ES2163144T3/es not_active Expired - Lifetime
- 1997-03-21 US US08/983,293 patent/US5932565A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990035844A (ko) | 1999-05-25 |
| PL324635A1 (en) | 1998-06-08 |
| CZ898A3 (cs) | 1998-06-17 |
| KR100478741B1 (ko) | 2005-07-07 |
| AU713630B2 (en) | 1999-12-09 |
| RU2169142C2 (ru) | 2001-06-20 |
| US5932565A (en) | 1999-08-03 |
| HUP9901600A3 (en) | 1999-11-29 |
| JP2000508635A (ja) | 2000-07-11 |
| NZ329531A (en) | 2001-03-30 |
| GB9607034D0 (en) | 1996-06-05 |
| CN1075809C (zh) | 2001-12-05 |
| DE69707121D1 (de) | 2001-11-08 |
| ES2163144T3 (es) | 2002-01-16 |
| PL186771B1 (pl) | 2004-02-27 |
| CZ290097B6 (cs) | 2002-05-15 |
| HUP9901600A2 (hu) | 1999-09-28 |
| CN1196720A (zh) | 1998-10-21 |
| WO1997037972A1 (en) | 1997-10-16 |
| EP0891326B1 (en) | 2001-10-04 |
| RO118286B1 (ro) | 2003-04-30 |
| ATE206394T1 (de) | 2001-10-15 |
| AU2567097A (en) | 1997-10-29 |
| EP0891326A1 (en) | 1999-01-20 |
| PT891326E (pt) | 2002-03-28 |
| DE69707121T2 (de) | 2002-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100451A1 (ru) | Замещенные аналоги бензопирана для лечения воспаления | |
| DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
| DE69217945D1 (de) | Azanorbornanderivate | |
| SE9604786D0 (sv) | New compounds | |
| DE69427704D1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane | |
| BR0309278A (pt) | Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto | |
| SE9502921D0 (sv) | New compounds | |
| BR0115936A (pt) | 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe | |
| SE9802206D0 (sv) | Novel compounds | |
| NO984330D0 (no) | Benzopyranderivater som har leukotrien-antagonistisk virkning | |
| DK0891326T3 (da) | Nye D-vitaminanaloger | |
| NO20014240D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| ATE345117T1 (de) | Biphenylverbindungen sowie ihre anwendung als östrogene mittel | |
| SE9504662D0 (sv) | New compounds | |
| UY26265A1 (es) | Compuestos calciolíticos | |
| DE69310904D1 (de) | Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung | |
| ES2089993T1 (es) | Procedimiento y productos intermediarios para la preparacion de clorhidrato de terazosin dihidrato. | |
| YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
| DE59809344D1 (de) | Disubstituierte biphenyloxazoline | |
| ES2140683T3 (es) | Procedimiento para preparar compuestos de benzopirano. | |
| SE9802207D0 (sv) | Novel compounds | |
| ATE285230T1 (de) | Verwendung von chrysanthon-naturstoffen, die eine antiangiogene wirkung haben |